Stocks · Health care · Pharmaceutical Preparations

BIOMARIN PHARMACEUTICAL INC

BMRN Clue Score68

United States Fiscal year ends December CIK 0001048477 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

19 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

George Eric Davis

EVP, Chief Legal Officer

—

$2.76M (2)

−$2.76M

61,003

0.0315%

$4.04M

+7.9%

Charles Greg Guyer

EVP, Chief Technical Officer

—

$996.74K (1)

−$996.74K

84,140

0.0435%

$5.58M

+12.8%

Gregory R Friberg

EVP, Chief R&D Officer

—

$558.62K (2)

−$558.62K

47,732

0.0247%

$3.16M

+62.0%

Alexander Hardy

Chief Executive Officer

—

—

—

214,635

0.1109%

$14.23M

+44.6%

Richard A Meier

Director

—

—

—

127,426

0.0658%

$8.45M

+5.5%

Brian Mueller

EVP, Chief Financial Officer

—

—

—

123,314

0.0637%

$8.17M

+71.4%

Robert J. Hombach

Director

—

—

—

49,360

0.0255%

$3.27M

+40.1%

Willard H Dere

Director

—

—

—

46,440

0.0240%

$3.08M

+43.8%

Cristin Hubbard

EVP, Chief Commercial Officer

—

—

—

42,472

0.0219%

$2.82M

+118.1%

Elizabeth M Anderson

Director

—

—

—

41,940

0.0217%

$2.78M

+50.9%

Maykin Ho

Director

—

—

—

35,500

0.0183%

$2.35M

+66.2%

Rashmi Virendra Ramchandani

VP, Chief Accounting Officer

—

—

—

25,610

0.0132%

$1.70M

—

Barbara W. Bodem

Director

—

—

—

21,045

0.0109%

$1.39M

+204.8%

Mark J Enyedy

Director

—

—

—

21,040

0.0109%

$1.39M

+204.9%

Athena Countouriotis

Director

—

—

—

21,040

0.0109%

$1.39M

+204.9%

Timothy P Walbert

Director

—

—

—

17,270

0.0089%

$1.14M

—

Ian T Clark

Director

—

—

—

14,490

0.0075%

$960.46K

—

Erin Burkhart

GVP, Chief Accounting Officer

—

—

—

14,173

0.0073%

$939.44K

−1.9%

Robert M Plenge

Director

—

—

—

6,140

0.0032%

$406.98K

—